| Business Type | Exporter, Supplier, Retailer, Trader, Distributor, Importer |
| Origin | Developed and manufactured by Eli Lilly and Company |
| Brand Name | Zepbound |
| Color | Clear, colorless solution |
| Click to view more | |
Product Details
Form
Liquid solution
Dosage Form
Available strengths include 5 mg, 7.5 mg, and 10 mg
Usage
Indicated for chronic weight management in adults with obesity or overweight with related conditions
Purity
Manufactured under strict quality controls with high peptide purity and sterility assurance
Feature
Dual GIP and GLP-1 receptor agonist (tirzepatide)
Zepbound is a prescription injectable medication containing tirzepatide, a dual GIP and GLP-1 receptor agonist. It is supplied as a single-dose, pre-filled injection pen and is approved for chronic weight management in adults with obesity or overweight with related medical conditions, under medical supervision.
Zepbound® is available in multiple strengths, including 5 mg, 7.5 mg, and 10 mg, allowing for gradual dose adjustment as prescribed. The injection is formulated as a clear, colorless solution intended for subcutaneous administration.
Manufactured by Eli Lilly and Company, Zepbound® is a prescription-only medicine, regulated and distributed according to regional health authority approvals.
Looking for "Zepbound Injection (5 Mg / 7.5 Mg / 10 Mg)" ?
Box
